Table 2.
Belespoir | Kodjo | Landja 1 | Landja 2 | Mangapou 2 | |
---|---|---|---|---|---|
Age-specific Ov16 results: n (%) | |||||
6 years | 0 (0) | 2 (10.0) | 4 (17.4) | 1 (2.8) | 0 (0) |
7 years | 0 (0) | 2 (40.0) | 1 (7.7) | 0 (0) | 0 (0) |
8 years | 0 (0) | 4 (33.3) | 1 (11.1) | 3 (13.6) | 1 (14.3) |
9 years | 0 (0) | 2 (15.4) | 1 (25.0) | 1 (3.2) | 0 (0) |
Overall a | 0 (0) | 10 (20.0) | 7 (14.3) | 5 (4.7) | 1 (4.2) |
Age-specific Lymphatic Filariasis (LF) results: n (%) | |||||
6 years | 0 (0) | 0 (0) | 0 (0) | 1 (2.8) | 0 (0) |
7 years | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
8 years | 0 (0) | 0 (0) | 0 (0) | 2 (9.5) | 0 (0) |
9 years | 0 (0) | 1 (7.7) | 0 (0) | 1 (3.2) | 0 (0) |
Overall b | 0 (0) | 1 (2.0) | 0 (0) | 4 (3.8) | 0 (0) |
a Overall Ov16 seroprevalence: 23/259 (8.9%); Difference across villages (Fisher exact test): p = 0.004. b Overall LF seroprevalence: 5/258 (1.9%); Difference across villages (Fisher exact test): p = 0.739.